Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducin.
about
G-protein-coupled receptors signaling pathways in new antiplatelet drug developmentPharmacokinetic drug evaluation of vorapaxar for secondary prevention after acute coronary syndrome.Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor MimeticsInterdicting Gq Activation in Airway Disease by Receptor-Dependent and Receptor-Independent Mechanisms.Matrix metalloproteases and PAR1 activation.Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease.Noncanonical matrix metalloprotease-1-protease-activated receptor-1 signaling triggers vascular smooth muscle cell dedifferentiation and arterial stenosis.Targeting platelet thrombin receptor signaling to prevent thrombosis.Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein.Preventing platelet thrombosis with a PAR1 pepducin.Pharmacology of antiplatelet agents.Vorapaxar in the secondary prevention of atherothrombosis.Targeting PAR1: Now What?Thrombin receptor antagonism in antiplatelet therapy.Pepducins and Other Lipidated Peptides as Mechanistic Probes and Therapeutics.Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptorsDysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2.Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin.Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function.Platelet Signaling Pathways and New Inhibitors.Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis.Novel aspects of antiplatelet therapy in cardiovascular disease
P2860
Q26864951-D1529F36-D8D1-42C1-B010-BE5A8A93DD0CQ30238719-67CEFC49-97F1-4F1B-A20A-8884528A4146Q35860717-96EE7D74-8069-497B-8B53-3D5E29EC58DAQ36432415-CC4BFA38-C9E0-4245-BE20-C17B6D666252Q36542806-98CDF9F9-7D15-46CF-93C1-48B6F9759257Q36813106-FF51019D-3024-48F4-8EBE-C2A44ACAEDAAQ37095396-A7431496-D3E8-41EB-9F18-37A94E2CBC37Q37280316-C4681CE2-81BE-418A-9975-7772C9DC8CD5Q37421226-38C35845-744F-438E-9F84-D587AF3DAFA6Q37587791-C1748A1F-8B15-41D1-A7A1-18C11EEDC76AQ38154211-49F7DE86-D8F5-4DD9-95E2-8C4A12172CACQ38630968-D8E79A9E-8E53-47F2-9914-F209447D2100Q39338913-108EDAA9-D634-43B0-8D0D-09088825EB23Q39410704-307CD2BA-97C6-4915-BB07-4E0D7DC35061Q40405065-57E92281-FB54-4C91-A16B-7695C2F6D241Q41151392-C5F52444-4846-4D0C-833B-07C5A812D2C2Q42479614-E4CEC752-77E9-4424-905F-D1873D6D20CAQ42725773-BBB9503A-5DED-42D2-A987-82D1D7DC79BFQ47153153-3A321633-566F-4AB1-9AB8-F3964648AC74Q52644169-3BBF23BD-EF36-45E3-8BA4-DB0E50A82673Q52721277-285BEF9E-15B8-4105-9D36-965DA9A63389Q57179203-9178C627-119F-40A6-9458-5796B9D89DC8
P2860
Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducin.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Suppression of arterial thromb ...... ell-penetrating PAR1 pepducin.
@ast
Suppression of arterial thromb ...... ell-penetrating PAR1 pepducin.
@en
Suppression of arterial thromb ...... ell-penetrating PAR1 pepducin.
@nl
type
label
Suppression of arterial thromb ...... ell-penetrating PAR1 pepducin.
@ast
Suppression of arterial thromb ...... ell-penetrating PAR1 pepducin.
@en
Suppression of arterial thromb ...... ell-penetrating PAR1 pepducin.
@nl
prefLabel
Suppression of arterial thromb ...... ell-penetrating PAR1 pepducin.
@ast
Suppression of arterial thromb ...... ell-penetrating PAR1 pepducin.
@en
Suppression of arterial thromb ...... ell-penetrating PAR1 pepducin.
@nl
P2093
P2860
P1433
P1476
Suppression of arterial thromb ...... ell-penetrating PAR1 pepducin.
@en
P2093
Andrew Bohm
András Gruber
Athan Kuliopulos
Carey Kimmelstiel
Daniel H Cox
James D Baleja
Katie O'Callaghan
Lidija Covic
Ping Zhang
Shogo Kasuda
P2860
P356
10.1161/CIRCULATIONAHA.112.091918
P407
P577
2012-06-15T00:00:00Z